ACTRN12612001305819尚未招募未知
Very low calorie diet (VLCD) followed by antibiotic, and prebiotic supplementation is superior to VLCD alone in achieving sustained weight loss and resolution of Non-Alcoholic Fatty Liver Disease.
Auckland District Health Board, Medical research unit0 个研究点目标入组 60 人开始时间: 2012年12月17日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Treatment
入排标准
- 年龄范围
- 16 Years 至 o limit（—）
- 性别
- All
入选标准
- •Non alcoholic fatty liver disease
排除标准
- •Alcohol >20g/d
- •Medications which cause steatohepatitis
- •Severe medical conditions
- •Allergy to metronidazole
- •Inflammatory bowel disease
- •Decompensated liver disease
研究者
相似试验
进行中（未招募）
不适用
A Randomized, Double-Blind, Placebo-Controlled, Clinical Evaluation of the Efficacy, Safety and Tolerability of Neramexane in Patients with Subjective TinnitusEfficacy, Safety and Tolerability of Neramexane in Patients with Subjective TinnitusMedDRA version: 9.1Level: LLTClassification code 10042398Term: Subjective tinnitusEUCTR2008-000639-16-CZMerz Pharmaceuticals GmbH400
进行中（未招募）
不适用
A Randomized, Double-Blind, Placebo-Controlled, Clinical Evaluation of the Efficacy, Safety and Tolerability of Neramexane in Patients with Subjective TinnitusEUCTR2007-007835-16-DEMerz Pharmaceuticals GmbH400
进行中（未招募）
1 期
A Randomized, Double-Blind, Placebo-Controlled, Clinical Evaluation of the Efficacy, Safety and Tolerability of Neramexane in Patients with Subjective TinnitusEfficacy, Safety and Tolerabilty of Neramexane in Patients with subjective TinnitusMedDRA version: 9.1 Level: LLT Classification code 10042398 Term: Subjective tinnitusEUCTR2007-007835-16-GBMerz Pharmaceuticals GmbH400
进行中（未招募）
不适用
A Randomized, Double-Blind, Placebo-Controlled, Clinical Evaluation of the Efficacy, Safety and Tolerability of Neramexane in Patients with Subjective TinnitusEfficacy, Safety and Tolerabilty of Neramexane in Patients with subjective TinnitusMedDRA version: 9.1Level: LLTClassification code 10042398Term: Subjective tinnitusEUCTR2007-007835-16-ATMerz Pharmaceuticals GmbH400
进行中（未招募）
1 期
A Randomized, Double-Blind, Placebo-Controlled, Clinical Evaluation of the Efficacy, Safety and Tolerability of Neramexane in Patients with Subjective TinnitusEUCTR2008-000639-16-FRMerz Pharmaceuticals GmbH400